Renaissance Technologies’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-278,400
Closed -$108K 3938
2020
Q1
$108K Buy
278,400
+37,686
+16% +$13.6K ﹤0.01% 3214
2019
Q4
$99K Sell
240,714
-288,261
-54% -$479K ﹤0.01% 3328
2019
Q3
$1.06M Sell
528,975
-38,673
-7% -$78.3K ﹤0.01% 2570
2019
Q2
$1.23M Sell
567,648
-53,300
-9% -$136K ﹤0.01% 2596
2019
Q1
$1.96M Sell
620,948
-97,100
-14% -$314K ﹤0.01% 2313
2018
Q4
$1.79M Sell
718,048
-21,200
-3% -$70.6K ﹤0.01% 2291
2018
Q3
$2.97M Buy
739,248
+133,825
+22% +$590K ﹤0.01% 2085
2018
Q2
$2.29M Buy
605,423
+76,510
+14% +$200K ﹤0.01% 2200
2018
Q1
$1.23M Buy
528,913
+42,300
+9% +$66.9K ﹤0.01% 2573
2017
Q4
$754K Buy
486,613
+75,200
+18% +$121K ﹤0.01% 2771
2017
Q3
$876K Buy
411,413
+60,700
+17% +$207K ﹤0.01% 2615
2017
Q2
$1.58M Buy
350,713
+97,300
+38% +$353K ﹤0.01% 2380
2017
Q1
$763K Buy
253,413
+38,400
+18% +$113K ﹤0.01% 2635
2016
Q4
$593K Buy
215,013
+52,400
+32% +$150K ﹤0.01% 2721
2016
Q3
$509K Buy
162,613
+72,400
+80% +$264K ﹤0.01% 2811
2016
Q2
$462K Buy
90,213
+24,900
+38% +$120K ﹤0.01% 2821
2016
Q1
$267K Buy
65,313
+3,100
+5% +$16.6K ﹤0.01% 3009
2015
Q4
$505K Sell
62,213
-4,400
-7% -$36.7K ﹤0.01% 2735
2015
Q3
$562K Sell
66,613
-25,034
-27% -$231K ﹤0.01% 2587
2015
Q2
$862K Sell
91,647
-5,466
-6% -$50.9K ﹤0.01% 2525
2015
Q1
$899K Buy
97,113
+20,000
+26% +$192K ﹤0.01% 2363
2014
Q4
$713K Sell
77,113
-7,000
-8% -$58.9K ﹤0.01% 2306
2014
Q3
$751K Sell
84,113
-59,185
-41% -$431K ﹤0.01% 2167
2014
Q2
$1.13M Sell
143,298
-77,315
-35% -$584K ﹤0.01% 2005
2014
Q1
$1.75M Buy
220,613
+1,700
+0.8% +$13.7K ﹤0.01% 1841
2013
Q4
$1.36M Buy
218,913
+8,800
+4% +$46.1K ﹤0.01% 1933
2013
Q3
$744K Buy
210,113
+10,300
+5% +$23.4K ﹤0.01% 2140
2013
Q2
$390K Buy
+199,813
New +$401K ﹤0.01% 2325